Neuroskeptic reviews the implications of the new/old interest in “dimensional” diagnosis in DSM-5 (which involves acknowledgment of symptoms across categories of diagnosis, rather than a strictly categorical approach), in light of DSM-5 task force chair David Kupfer’s financial interest in a company that provides such an assessment via computer. Kupfer and Robert Gibbons published an article on the method in JAMA Psychiatry, neglecting to mention the conflict of interest.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.